These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6275706)

  • 1. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
    Gerdes LC; Sonnendecker EW; Polakow ES
    Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
    Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psycho-endocrine differences and correlations in symptomatic and asymptomatic climacteric women - the possible role of prolactin.
    Sonnendecker EW; Polakow ES; Gerdes L
    S Afr Med J; 1981 Oct; 60(17):661-5. PubMed ID: 6272429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonographic changes in the endometrium of climacteric women during hormonal treatment.
    Schurz B; Metka M; Heytmanek G; Wimmer-Greinecker G; Reinold E
    Maturitas; 1988 Mar; 9(4):367-74. PubMed ID: 2837621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the climacteric syndrome. Controlled study of a combination of low-dose clonidine and low-dose conjugated estrogens].
    Schindler AE; Heners D; Pater T; Wendel U; Donath EM
    Fortschr Med; 1984 Dec; 102(47-48):1213-6. PubMed ID: 6097521
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oestrogen replacement in the climacteric syndrome.
    Strickler RC; Borth R; Cecutti A; Cookson BA; Harper JA; Potvin R; Riffel P; Sorbara VJ; Woolever CA
    Psychol Med; 1977 Nov; 7(4):631-9. PubMed ID: 201958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The climacteric syndrome: an estrogen replacement dilemma.
    Strickler RC; Borth R; Woodlever CA
    Can Med Assoc J; 1977 Mar; 116(6):586-7. PubMed ID: 204404
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.
    Place VA; Powers M; Darley PE; Schenkel L; Good WR
    Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
    Tulandi T; Lal S; Guyda H
    J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of estrogen supplementation on psychological variables in climacteric women].
    Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
    Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychometric aspects of estrogen therapy in climacteric woman (study of 122 women after menopause].
    Wenderlein JM
    Z Klin Psychol Psychother; 1981; 29(3):263-7. PubMed ID: 6274104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.
    Ross LA; Alder EM; Cawood EH; Brown J; Gebbie AE
    J Psychosom Obstet Gynaecol; 1999 Jun; 20(2):88-96. PubMed ID: 10422040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postmenopausal hormone therapy after WHI and HERS].
    Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
    [No Abstract]   [Full Text] [Related]  

  • 19. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
    Wesel S; Bourguignon RP; Bosuma WB
    Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.